Search

Search Constraints

You searched for: Author/Creator Szczepanski, Tomasz

Search Results

1. Biallelic loss of CDKN2A is associated with poor response to treatment in pediatric acute lymphoblastic leukemia. Issue 5 (4th May 2017)

2. Clinical Implications of Minimal Residual Disease Detection in Infants With KMT2A-Rearranged Acute Lymphoblastic Leukemia Treated on the Interfant-06 Protocol. Issue 6 (20th February 2021)

3. Detailed immunophenotyping of B‐cell precursors in regenerating bone marrow of acute lymphoblastic leukaemia patients: implications for minimal residual disease detection. (17th April 2017)

4. Flow cytometric minimal residual disease assessment in B‐cell precursor acute lymphoblastic leukaemia patients treated with CD19‐targeted therapies — a EuroFlow study. (8th December 2021)

5. GATA3 germline variant is associated with CRLF2 expression and predicts outcome in pediatric B‐cell precursor acute lymphoblastic leukemia. Issue 9 (3rd April 2019)

6. Global effort to evacuate Ukrainian children with cancer and blood disorders who have been affected by war. Issue 9 (September 2022)

7. Individualized tumor response testing profile has a prognostic value in childhood acute leukemias: multicenter non-interventional long-term follow-up study. Issue 6 (1st June 2013)

8. Individualized tumor response testing profile has a prognostic value in childhood acute leukemias: multicenter non-interventional long-term follow-up study. Issue 6 (June 2013)

9. Infectious complications in children treated for hodgkin and non-hodgkin lymphomas in polish pediatric leukemia/lymphoma study group: incidence, epidemiology and etiology. Issue 1 (2nd January 2019)